3.95
Aurora Cannabis Inc. stock is traded at $3.95, with a volume of 677.38K.
It is up +1.54% in the last 24 hours and up +40.57% over the past month.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
See More
Previous Close:
$3.89
Open:
$3.89
24h Volume:
677.38K
Relative Volume:
0.49
Market Cap:
$250.07M
Revenue:
$267.06M
Net Income/Loss:
$-69.17M
P/E Ratio:
-3.4937
EPS:
-1.1306
Net Cash Flow:
$-22.38M
1W Performance:
-1.50%
1M Performance:
+40.57%
6M Performance:
+8.22%
1Y Performance:
-18.22%
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ACB
Aurora Cannabis Inc.
|
3.95 | 241.21M | 267.06M | -69.17M | -22.38M | -1.1306 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Dec-11-24 | Initiated | TD Cowen | Buy |
| Feb-09-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Why Is Aurora Cannabis Inc (TSX:ACB) Turning Heads In Cannabis Stocks? - Kalkine Media
Aurora Cannabis Rejects Curaleaf Offer as Inadequate - WSJ
Aurora Cannabis Inc. (ACB): The Canadian Health Stock Investors May Want on Their Radar - kalkine.ca
Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
Aurora Cannabis Inc. stock rises Friday, outperforms market - MarketWatch
Aurora Cannabis (NASDAQ:ACB): Can Sector Momentum Lift the Stock? - Kalkine Media
Aurora Cannabis Urges Shareholders to Reject Curaleaf’s Hostile Takeover - Ganjapreneur
Aurora Cannabis Stock Slides 3.59% as Selling Pressure Returns: Can Global Medical Cannabis Growth Stabilize TSX:ACB? - kalkine.ca
Aurora Cannabis Falls Under Pressure as Sentiment Weakens and Strategic Uncertainty Builds - kalkine.ca
Why Is Aurora Cannabis (NASDAQ:ACB) Board Telling Stockholders to Reject Curaleaf's Unsolicited Bid? - Kalkine Media
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Aurora Cannabis (NASDAQ:ACB) In Focus Amid Changing Market Themes - Kalkine Media
Aurora Cannabis (NASDAQ:ACB) Draws Fresh Focus As Sector Shifts - Kalkine Media
Promising Cannabis Stocks To Follow TodaySeptember 3rd - MarketBeat
Aurora Cannabis Board Recommends Rejecting Curaleaf Bid - Yahoo Finance
Aurora Cannabis Urges Shareholders to Reject Curaleaf Hostile Takeover - Cannabis Equipment News
Aurora Rejects Curaleaf Bid, Opens Door to Other Offers - mg Magazine
Aurora Cannabis urges shareholders to reject hostile takeover offer by Curaleaf - CBC
Aurora Cannabis board rejects offer from Curaleaf (ACB:NASDAQ) - Seeking Alpha
Curaleaf (CURLF) answers Aurora Cannabis in new release - Stock Titan
Aurora Board Unanimously Rejects Curaleaf Proposal While US Company Counters - stratcann.com
Promising Cannabis Stocks To Watch NowSeptember 2nd - MarketBeat
Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid - Benzinga
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders - PR Newswire Canada
Aurora Cannabis Urges Shareholders to Reject Curaleaf's Hostile Bid - Cannabis Business Times
Aurora's board tells shareholders to reject Curaleaf's bid and withdraw tendered shares - MMJDaily
Aurora Cannabis urges shareholders to reject Curaleaf bid By Investing.com - Investing.com South Africa
Aurora Cannabis board rejects Curaleaf's unsolicited takeover bid - StreetInsider
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk - The Globe and Mail
Aurora Cannabis Inc (ACB-T) Stock Price and News - The Globe and Mail
Will Aurora Cannabis (NASDAQ:ACB) Stock Owners Back a Hostile Bid? - Kalkine Media
Aurora Cannabis Inc. Is Betting on Global Medical — Is ACB Finally a Higher-Quality Cannabis Story? - kalkine.ca
Top Cannabis Stocks Worth WatchingSeptember 1st - MarketBeat
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid? - Yahoo Finance
Aurora Cannabis Inc. stock rises Tuesday, outperforms market - MarketWatch
Aurora Cannabis Highlights Inaccuracies In Curaleaf’s Takeover Bid Announcement— CEO Claims Business Is Reaching Pivotal Inflection Point - Stocktwits
Aurora Cannabis rejects Curaleaf takeover bid as opportunistic - Investing.com
Aurora Cannabis (NASDAQ:ACB) Global Medical Strategy Under Focus - Kalkine Media
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell? - TradingView
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - Yahoo Finance
StockTalk | Cannabis Report: Hostile takeover? | 2026-08-21 | Investing News - Stockhouse
Aurora Cannabis Company Profile & Introduction - Moomoo
Aurora Cannabis Acquires Internode Pharma, HAP Pharma, Expanding Distribution Access to UK - Cannabis Business Times
Aurora Cannabis expands in UK market through acquisitions - The Pharma Letter
Small caps to watch: Roots announces go-private deal, along with updates from Questerre Energy, Tilray and Aurora - The Globe and Mail
Aurora expands UK distribution with new company acquisitions - MMJDaily
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way? - Yahoo Finance
Can Aurora Cannabis (TSX:ACB) Defy Changing Market Sentiment? - Kalkine Media
Aurora Cannabis Inc. stock rises Wednesday, outperforms market - MarketWatch
Aurora Cannabis Buys Internode Pharma & HAP Pharma - TradingView
Aurora Cannabis Buys U.K. Importer and Pharmacy to Deepen Medical Cannabis Reach - TipRanks
Aurora Cannabis Inc. Stock (ACB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):